• Topical IMQ treatment induced a psoriatic-like phenotype in mouse skin. • Skin IMQ treatment induced inflammation and signs of metabolic dysfunction in sub-cutaneous and epidydimal adipose tissue, liver, skeletal muscle and gut tissue. • Skin IMQ treatment induced islet compensation characterised by increased insulin and c-peptide response to glucose, and increased beta cell proliferation. • The in vivo IMQ mouse phenotype is partially replicated by exposure of sAT and pancreatic islets to psoriatic-skin conditioned media. • Psoriatic skin inflammation, potentially through the endocrine actions of the skin secretome, may constitute a novel pathophysiological pathway mediating the development of T2D.